PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides to reveal your genetic response profile, predicting whether semaglutide, tirzepatide, or dual GLP-Squared compounds suit you best
According to Rubino, clinical trials are now being planned to assess whether higher doses of GLP-1 drugs can be used in the acute phase to help patients lose weight, followed by lower "maintenance" doses, which come with fewer side effects and can be prescribed on a long-term basis
Read more obesity medicine news: Subscribe to my free newsletter: All my links: If you found this helpful, please Like, Subscribe, and Share this episode with someone navigating obesity, diabetes, or GLP-1 treatment
But Simtriyo may not be for everyone